[Principles for testing potential immunomodulators in the cancer clinic].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods; D003131:Combined Modality Therapy; D004306:Dose-Response Relationship, Immunologic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology
D000276:Adjuvants, Immunologic
Printsipy ispytaniia potentsial'nykh immunomoduliatorov v onkologicheskoĭ klinike.